AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-854

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,751 Posts.
    lightbulb Created with Sketch. 782
    Sir John Bell, a Regius professor of medicine at Oxford University, who is leading the testing effort, said the assessments were ongoing and that his group was talking to companies in the hope of improving the antibody tests, adding that “a lot of the tests look very similar and probably come from the same factory in China”.

    The Oxford group has characterised six different antibody tests and found that most fall well short of the accuracy required. Most failed to detect antibodies half the time and the best spotted the immune cells only 70% of the time. If used at scale, the tests could leave millions of people who have immunity convinced they are still vulnerable to the infection. For the test to pass, the accuracy would have to be nearer 95%.

    https://www.theguardian.com/world/2020/apr/09/uk-government-urged-to-abandon-poor-finger-prick-antibody-tests-coronavirus#maincontent
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.